X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (7) 7
humans (5) 5
oncology (5) 5
vismodegib (5) 5
female (4) 4
hematology (4) 4
male (4) 4
analysis (3) 3
basal cell carcinoma (3) 3
care and treatment (3) 3
cyclophosphamide (3) 3
hedgehog pathway inhibitor (3) 3
life sciences (3) 3
neoplasms. tumors. oncology. including cancer and carcinogens (3) 3
patients (3) 3
studies (3) 3
aged (2) 2
antibodies, monoclonal, humanized - administration & dosage (2) 2
antimitotic agents (2) 2
antineoplastic agents (2) 2
bendamustine hydrochloride - administration & dosage (2) 2
cancer (2) 2
clinical trials (2) 2
complications and side effects (2) 2
disease-free survival (2) 2
follicular lymphoma (2) 2
free survival (2) 2
ga101 (2) 2
hematologic malignances (2) 2
hematopoiesis (2) 2
lymphoma, non-hodgkin - drug therapy (2) 2
lymphomas (2) 2
medical prognosis (2) 2
medical research (2) 2
medicine & public health (2) 2
medicine, experimental (2) 2
metastases (2) 2
middle aged (2) 2
myelofibrosis (2) 2
research (2) 2
response rates (2) 2
rituximab (2) 2
rituximab - administration & dosage (2) 2
ruxolitinib (2) 2
safety (2) 2
survival (2) 2
survival rate (2) 2
therapy (2) 2
thrombocytopenia (2) 2
toxicity (2) 2
trial (2) 2
tumors (2) 2
[ sdu.stu.oc ] sciences of the universe [physics]/earth sciences/oceanography (1) 1
[ sdv.bid ] life sciences [q-bio]/biodiversity (1) 1
[ sdv.can ] life sciences [q-bio]/cancer (1) 1
[ sdv.mp.vir ] life sciences [q-bio]/microbiology and parasitology/virology (1) 1
[sdu.stu.oc]sciences of the universe [physics]/earth sciences/oceanography (1) 1
[sdv.bid]life sciences [q-bio]/biodiversity (1) 1
[sdv.mp.vir]life sciences [q-bio]/microbiology and parasitology/virology (1) 1
abridged index medicus (1) 1
alignment (1) 1
alopecia (1) 1
anemia (1) 1
anilides - adverse effects (1) 1
anilides - therapeutic use (1) 1
antibodies (1) 1
antibody (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - administration & dosage (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
apoptosis (1) 1
asia (1) 1
atp-binding cassette transporters - antagonists & inhibitors (1) 1
b-cell lymphoma (1) 1
bacteriophage (1) 1
basal-cell carcinoma (1) 1
biodiversity (1) 1
biogeochemical cycles (1) 1
biogeochemistry (1) 1
biomarkers (1) 1
bone imaging (1) 1
bone marrow (1) 1
breast-cancer (1) 1
canada (1) 1
cancer clinical-trials (1) 1
cancer therapies (1) 1
cancer-therapy (1) 1
carcinoma, basal cell - drug therapy (1) 1
carcinoma, basal cell - pathology (1) 1
cell lymphoma (1) 1
chemotherapy (1) 1
chronic lymphocytic-leukemia (1) 1
clinical-trials (1) 1
criteria (1) 1
cytotoxicity (1) 1
datasets (1) 1
datasets as topic (1) 1
dermatology (1) 1
development and progression (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1081 - 1093
Journal Article
Journal Article
Journal Article
British Journal of Haematology, ISSN 0007-1048, 05/2019, Volume 185, Issue 3, pp. 595 - 598
Table S3. Adverse events of all grades occurring in a[yen]20% of all treated patients. 
stem cells | vismodegib | leukaemia | Hedgehog signalling | MALIGNANCIES | HEMATOLOGY | Clinical trials | Stem cells | Vismodegib | Refractory materials | Leukemia
Journal Article
BMC cancer, ISSN 1471-2407, 04/2019, Volume 19, Issue 1, pp. 366 - 1
Following publication of the original article [1], it was reported that the legend for Fig. 1 was incomplete. The complete figure legend is. 
Journal Article
2017
Clinical trials can be lengthy and costly, with new treatments taking more than a decade to become available to the patients who need them. It is therefore of... 
Dissertation
Journal Article
European Journal of Dermatology, ISSN 1167-1122, 11/2018, Volume 28, Issue 6, pp. 775 - 783
Health-related quality of life (HRQoL) data are limited in patients with advanced basal cell carcinoma.To report HRQoL outcomes based on STEVIE (NCT01367665),... 
Medicine & Public Health | Dermatology | basal cell carcinoma | HRQoL | vismodegib | locally advanced | STEVIE | Hedgehog pathway inhibitor | NONMELANOMA SKIN-CANCER | OUTCOMES | DERMATOLOGY | Life Sciences | Human health and pathology
Journal Article
09/2016, Volume 537
Ocean microbes drive biogeochemical cycling on a global scale. However, this cycling is constrained by viruses that affect community composition, metabolic... 
Publication
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.